Elutia Inc.

ELUT Healthcare Medical Devices

In the quarter to June 2026, revenue fell 11.7%, EPS grew 26.1% and free cash flow fell 2.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.79 0.00 0.00%
Market cap
$34.9M
P/E
0.6×
Fwd P/E
−1.7×
Dividend yield
—
F-score
5/9
Altman Z
−4.10
Beneish M
0.81
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
6 5 5 3

+8 more TTM periods

ROE
(454.01%) (790.25%) (574.35%) 80.06%
ROA
152.89% 116.49% 108.41% (86.58%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
310.30% 198.18% 160.83% 161.17%
Average Days of Receivables
399.77 451.74 432.90 432.92
Free Cash Flow per Share
(1.04) (1.07) (1.13) (0.79)
Free Cash Flow
(46.03) (45.82) (46.69) (33.37)
Other line items

Show all line items

Columns are period end dates